Muse Biotechnologies
4001 Discovery Drive
Suite N321, UCB 027
Boulder
Colorado
80309
United States
Tel: 720-480-9235
Website: http://www.musebio.com/
Email: info@musebio.com
About Muse Biotechnologies
Muse bio is transforming genome engineering by enabling, for the first time, high throughput massively-multiplexed CRISPR editing of proteins, pathways, and genomes. Through our powerful bioinformatics and novel molecular approach, ForgeCraft generates low-cost libraries of thousands of designer protein, pathway, or genome variants each with specifically defined, trackable mutations. This allows the impact of specific changes to be determined through rapid selection and high throughput screening allowing research timelines and costs to be reduced.
YEAR FOUNDED:
2015
LEADERSHIP:
Founder and CSO: Ryan T Gill PhD
Founder, CTO and VP R&D: Tanya Lipscomb PhD
CEO: Kevin Ness, PhD
VP, Finance: Erik Warneke
VP, Corporate Development: Joey Money PhD
TECHNOLOGY:
Please click here for Muse bio's technology.
6 articles about Muse Biotechnologies
-
Here’s a roundup of biopharma companies that have announced hiring trends since the beginning of the year.
-
The mysterious death of a biotech startup chief executive officer in late April projected the term biohacker into the forefront of the industry lexicon.
-
Gene-editing company Inscripta, formerly known as Muse Biotechnologies, will be able to expand its research capabilities and increase hiring after the company closed a Series C funding round of $55.5 million.
-
Muse bio Appoints Genomics Industry Expert, John Stuelpnagel, As Chairman Of The Board Of Directors
5/9/2017
-
Colorado's Muse bio Secures $23 Million Series B
2/28/2017
-
Muse bio Taps Biotech Vet as New CEO
12/7/2016